CTOs on the Move

Ocular Therapeutix

www.ocutx.com

 
Founded in 2006, Ocular Therapeutix is a fast-growing, aspiring leader in the biopharmaceutical industry. The company has a clear vision – to improve current therapeutic options in ophthalmology by encapsulating previously approved therapeutic agents in our novel hydrogel to provide a sustained delivery of drugs to the eye. We are reframing the industry with new modalities for ophthalmic therapies. As a small company, our employees are provided the unique opportunity to help build the foundation of the business as it grows. We strongly believe that our success is contingent upon the achievements of our employees. We strive to create a ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ocutx.com
  • 34 Crosby Drive Ste 105
    Bedford, MA USA 01730
  • Phone: 781.357.4000

Executives

Name Title Contact Details
Steve Fedan
Director of Information Technology Profile

Funding

Ocular Therapeutix raised $35.1M on 01/30/2018

Similar Companies

Medex Supply

With one of the largest catalogs of medical, surgical, and diagnostic supplies available online, Medex Supply can provide your facility with all the medical equipment necessary to ensure a healthy, safe, and sterile environment. Our extensive selection, low prices, fast shipping, and friendly, knowledgeable customer service makes Medex Supply a #1 favorite with universities, hospitals, doctors, nurses, schools, laboratories, government agencies, and more.

LipoSonix

LipoSonix is a Bothell, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AandM Instruments Inc

A&M Instruments Inc is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MJS BioLynx

MJS BioLynx Inc. is a Brockville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accelmed Growth Partners

Accelmed is an investment firm focused on value creation for medical device companies and technologies. Accelmed was founded in 2009 by Mori Arkin and Uri Geiger and invests in small and mid-cap private and public companies.